Loretta J. Nastoupil, MD, University of Texas MD Anderson Cancer Center
Advertisement
Articles by Loretta J. Nastoupil, MD, University of Texas MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Looking at the Big Picture in DLBCLPublished: August 23rd 2021 | Updated:
CAR T for R/R FL: Treatment ConsiderationsPublished: April 19th 2021 | Updated:
Treating Patients Post CAR T TherapyPublished: August 23rd 2021 | Updated:
Recommendations for Second-Line Therapy in DLBCLPublished: July 26th 2021 | Updated:
Novel Therapies for R/R Follicular LymphomaPublished: April 19th 2021 | Updated:
Treating Follicular Lymphoma With Early ProgressionPublished: April 5th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5